No Data
No Data
Earnings Preview: TMO to Report Financial Results Pre-market on April 23
Wells Fargo Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $580
Express News | Wells Fargo Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $580
Thermo Fisher Scientific Analyst Ratings
Immune Repertoire Sequencing Market Worth US$560.5 Million by 2030 With 9.6% CAGR | MarketsandMarkets
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development
loading...